mylan laboratories inc ftc clears purchase of merck kgaa unit the u s federal trade commission approved mylan laboratories inc s acquisition of merck kgaas generics unit after the companies agreed to sell assets related to five drugs the companies will sell the five generic drugs to amneal pharmaceuticals llc a privately owned u s company the ftc said mylans deal to buy the german companys generics unit was valued at &# billion when it was announced in may the drugs are four hypertension treatments and an arrhythmia medicine without the divestitures the deal "would result in reduced competition and higher prices for u s consumers of several important generic pharmaceuticals " said jeffrey schmidt director of the ftcs bureau of competition the agreement "will ensure that competition is maintained following completion of this acquisition " mr schmidt said 
